FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247248192> ?p ?o ?g. }

• W4247248192 abstract "Detection of hepatitis C virus (HCV) RNA in samples of plasma/serum has become an essential part of the diagnosis and management of HCV-infected patients. Qualitative HCV-RNA tests are used to identify acute HCV infections as well as chronic HCV carriers.In recent years,a variety of commercial and non commercial test systems have been developed for this purpose. Each of these methods is calibrate with proprietary standards and exhibits its own sensitivity (detection limit) and specificity. Obviously, laboratories performing HCV-RNA test should report accurate and reliable results regardless of the type of assay used.Where commercial kit are used for part of or the complete analytical procedure, documented validation points already covered by the kit manufacturer can substitute for the validation by the user.Nevertheless, the performance of the kit with respect to its intended use has to be demonstrated by the user. One of the best ways to assess the performance of individual laboratories for validation of qualitative HCV-RNA test is determine: 1. Specificity. In order to validate the specificity of the analytical procedure, at least 100 HCV-RNA-negative plasma pools should be tested and shown to be non-reactive. 2. Positive cut-off point (detection limit/sensitivity).The positive cut-off point (as defined in the Ph Eur General Method 2. 6. 21) is the minimum number of the target sequences per volume sample which can be detected in 95% of test runs.A dilution series of a working reagent or reference material, which has been calibrated against the WHO HCV International Standard (96/790), should be tested on different days to examine variation between test runs.At least 3 independent dilution series should be tested with a sufficient number of replicates at each dilution to give a total number of 24 test results for each dilution to enable a statistical analysis of the results; 3. Robustness.To demonstrate robustness, at least 20 HCV-RNA negative plasma pools (selected at random) and spiked with HCV-RNA to a final concentration of 3 times the previously determined 95% cut-off value should be tested and found positive; 4. Cross-contamination error.Cross-contamination prevention should be demonstrated by the accurate detection of a panel of at least 20 samples consisting of alternate samples of negative plasma pools and negative plasma pools spiked with high concentrations of HCV (at least 102 x the 95% cut-off value or at least 104 IU/ml)." @default.
• W4247248192 created "2022-05-12" @default.
• W4247248192 creator A5018107636 @default.
• W4247248192 creator A5023774292 @default.
• W4247248192 creator A5043095068 @default.
• W4247248192 creator A5071325152 @default.
• W4247248192 date "2004-03-30" @default.
• W4247248192 modified "2023-10-16" @default.
• W4247248192 title "Il controllo di qualità nell’impiego della PCR applicata alla determinazione qualitativa dell’HCV-RNA" @default.
• W4247248192 doi "https://doi.org/10.4081/mm.2004.3023" @default.
• W4247248192 hasPublicationYear "2004" @default.
• W4247248192 type Work @default.
• W4247248192 citedByCount "0" @default.
• W4247248192 crossrefType "journal-article" @default.
• W4247248192 hasAuthorship W4247248192A5018107636 @default.
• W4247248192 hasAuthorship W4247248192A5023774292 @default.
• W4247248192 hasAuthorship W4247248192A5043095068 @default.
• W4247248192 hasAuthorship W4247248192A5071325152 @default.
• W4247248192 hasBestOaLocation W42472481921 @default.
• W4247248192 hasConcept C104317684 @default.
• W4247248192 hasConcept C119128265 @default.
• W4247248192 hasConcept C153911025 @default.
• W4247248192 hasConcept C159047783 @default.
• W4247248192 hasConcept C185592680 @default.
• W4247248192 hasConcept C2522874641 @default.
• W4247248192 hasConcept C2776408679 @default.
• W4247248192 hasConcept C2776455275 @default.
• W4247248192 hasConcept C43617362 @default.
• W4247248192 hasConcept C55493867 @default.
• W4247248192 hasConcept C67705224 @default.
• W4247248192 hasConcept C71924100 @default.
• W4247248192 hasConcept C86803240 @default.
• W4247248192 hasConceptScore W4247248192C104317684 @default.
• W4247248192 hasConceptScore W4247248192C119128265 @default.
• W4247248192 hasConceptScore W4247248192C153911025 @default.
• W4247248192 hasConceptScore W4247248192C159047783 @default.
• W4247248192 hasConceptScore W4247248192C185592680 @default.
• W4247248192 hasConceptScore W4247248192C2522874641 @default.
• W4247248192 hasConceptScore W4247248192C2776408679 @default.
• W4247248192 hasConceptScore W4247248192C2776455275 @default.
• W4247248192 hasConceptScore W4247248192C43617362 @default.
• W4247248192 hasConceptScore W4247248192C55493867 @default.
• W4247248192 hasConceptScore W4247248192C67705224 @default.
• W4247248192 hasConceptScore W4247248192C71924100 @default.
• W4247248192 hasConceptScore W4247248192C86803240 @default.
• W4247248192 hasIssue "1" @default.
• W4247248192 hasLocation W42472481921 @default.
• W4247248192 hasOpenAccess W4247248192 @default.
• W4247248192 hasPrimaryLocation W42472481921 @default.
• W4247248192 hasRelatedWork W1975423158 @default.
• W4247248192 hasRelatedWork W1986137505 @default.
• W4247248192 hasRelatedWork W2016968193 @default.
• W4247248192 hasRelatedWork W2059010078 @default.
• W4247248192 hasRelatedWork W2068259734 @default.
• W4247248192 hasRelatedWork W2083266836 @default.
• W4247248192 hasRelatedWork W2096288449 @default.
• W4247248192 hasRelatedWork W2105597814 @default.
• W4247248192 hasRelatedWork W2106406452 @default.
• W4247248192 hasRelatedWork W2142935324 @default.
• W4247248192 hasVolume "19" @default.
• W4247248192 isParatext "false" @default.
• W4247248192 isRetracted "false" @default.
• W4247248192 workType "article" @default.